Tsubota Laboratory Incorporated
R&D company developing treatments for ophthalmology and CNS disorders.
4890 | T
Overview
Corporate Details
- ISIN(s):
- JP3535700003
- LEI:
- Country:
- Japan
- Address:
- 新宿区信濃町35 慶應義塾大学信濃町キャンパス2号館9階CRIK信濃町E7
- Website:
- https://tsubota-lab.com/en/
Description
Tsubota Laboratory Incorporated is a research and development company that originated as a startup from Keio University. It is engaged in the creation of pharmaceuticals and medical devices. The company's primary focus is on ophthalmology, developing solutions for conditions such as myopia, dry eye, and presbyopia. Additionally, it explores treatments for central nervous system (CNS) disorders and brain diseases. The corporate strategy centers on out-licensing its developed pipelines to commercial partners. A notable pipeline is a therapeutic candidate designed to curtail the progression of myopia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-06-29 08:24 |
確認書
|
Japanese | 8.9 KB | ||
| 2022-06-29 08:23 |
有価証券報告書-第10期(令和3年4月1日-令和4年3月31日)
|
Japanese | 1.9 MB | ||
| 2022-06-15 08:00 |
訂正有価証券届出書(新規公開時)
|
Japanese | 1.8 MB | ||
| 2022-06-07 08:00 |
訂正有価証券届出書(新規公開時)
|
Japanese | 1.8 MB | ||
| 2022-05-20 08:00 |
有価証券届出書(新規公開時)
|
Japanese | 3.6 MB |
Automate Your Workflow. Get a real-time feed of all Tsubota Laboratory Incorporated filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tsubota Laboratory Incorporated
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tsubota Laboratory Incorporated via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||